Add to Favorites Newsroom RSS Share
1030 Vienna, Austria

Our News on Newswise

Building block of "happiness hormone" is key to controlling immunity in cancer and auto-immune diseases.

Scientists at IMBA - Institute of Molecular Biotechnology at the Austrian Academy of Sciences - together with the Boston Children's Hospital at Harvard, demonstrate a completely new way of combating autoimmune diseases and cancer.
6-Nov-2018 1:00 PM EST Add to Favorites

Principles of Limb Regeneration in Salamanders Show Link to Mammals

Scientists have long argued over which cells enable salamanders to grow back lost limbs. By tracking lineages and characterising individual cells, researchers could now show that connective tissue cells develop stem-cell-like properties and underlie...
27-Sep-2018 11:00 AM EDT Add to Favorites

“Bouncer”, the Gate-Keeper of the Egg, Controls Sperm Entry

Fertilisation is a pivotal process underlying all sexual reproduction, yet its molecular mechanisms are poorly understood. Scientists at the Research Institute of Molecular Pathology (IMP) in Vienna have now identified a protein they called...
7-Sep-2018 3:05 AM EDT Add to Favorites

Growing Brain Cancer in a Dish

For the first-time, researchers at IMBA- Institute of Molecular Biotechnology of the Austrian Academy of Sciences – develop organoids, that mimic the onset of brain cancer. This method not only sheds light on the complex biology of human brain...
20-Jul-2018 6:00 PM EDT Add to Favorites

Not Just Housekeeping: A New Way to Control Protein Production in Stem Cells

Cells acquire distinct fates and functions during development. A study from the IMBA reveals a new mechanism of cell fate specification involving the regulation of cell metabolism.
4-Apr-2018 4:05 AM EDT Add to Favorites


Groundbreaking Technique to Study MicroRNAs in Single Cells of Living Animals

Scientists from two institutes at the Vienna BioCenter (VBC) have developed a method to identify and characterise microRNAs in individual cells of living animals.
21-Mar-2018 8:05 AM EDT Add to Favorites

The Largest Genome Ever: Decoding the Axolotl 

Scientists in Vienna, Dresden and Heidelberg have decoded the entire genetic information of the Mexican salamander axolotl, the largest genome ever to be sequenced. This will be a powerful tool to study the molecular basis of regeneration. The...
24-Jan-2018 7:30 AM EST Add to Favorites

Taking Screening Methods to the Next Level

CRISPR-UMI, a novel method developed at IMBA, facilitates extremely robust and sensitive screens by tracking single mutants within a population of cells.
16-Oct-2017 2:05 AM EDT Add to Favorites

see all news

Our Experts on Newswise

Scientists Initiate First Ethical Guidelines for Organs Cultivated in Vitro

In the latest edition of the journal “Science”, Jürgen Knoblich, a leading authority on stem cells and deputy director of the IMBA (Institute for Molecular Biotechnology of the Austrian Academy of Sciences), together with international experts,...
18-Jan-2017 3:05 AM EST

see all experts

Our YouTube Videos


The Research Institute of Molecular Pathology (IMP) in Vienna is a basic biomedical research institute largely sponsored by Boehringer Ingelheim. With over 200 scientists from 30 nations, the IMP is committed to scientific discovery of fundamental molecular and cellular mechanisms underlying complex biological phenomena. Research areas include cell and molecular biology, neurobiology, disease mechanisms and computational biology. The IMP is a founding member of the Campus Vienna Biocenter.


Heidemarie Hurtl

+43 1 797 30-3625


Chat now!